ARCHIVES

FDA Plans Greater Disclosures Over Wide Range Of Activities

This article is from The Cancer Letter archive.

Vol. 36 No. 19 | May 21, 2010

Download PDF Visit The Full Archive

Related Articles

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

NIH Begins Undiagnosed Diseases Program.

May 30, 2008

Harkin, Hatfield Propose Trust Fund to Raise Research Funding

May 28, 1993

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

In Brief: Centers Survey Generates Only 56 Responses GAO to Report On NCI’s Dissemination Efforts

January 22, 1988